From the impact of Obamacare to cutting-edge research, biotech buyouts to Big Pharma court battles, The Motley Fool's health-care team sits down each week to discuss the most fascinating developments in health care, and their implications for long-term investors. In this week's edition, the team talks about Novartis' patent dispute, stocks that have both popped and plummeted, and the companies our analysts will be watching in the coming days.

In the following segment, health-care analyst David Williamson discusses two big developments with retail pharmacies that are affecting consumers. Watch and find out why you might be ditching your family doctor for a Walgreen and where you can get the cheapest generic drugs. Fool on!

Brenton Flynn, Max Macaluso, Ph.D., and David Williamson have no position in any stocks mentioned. Follow David on Twitter: @MotleyDavid

The Motley Fool recommends and owns shares of Costco Wholesale. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.